|BIBCL -- India Stock|| |
INR 11.26 0.37 3.18%
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Current Valuation Analysis
Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
| = |
Market Cap + Debt
| = |
About Current Valuation
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
In accordance with recently published financial statements Bharat Immunologicals Biologicals Corp Ltd has Current Valuation of 361.69M. This is 99.34% lower than that of the Healthcare sector, and 98.97% lower than that of Biotechnology
industry, The Current Valuation for all stocks is 99.76% higher than the company.